|
Discover SuperSonic® MACH® 30
for confident breast imaging
Bring confidence to your facility with the SuperSonic MACH 30, an
innovative software-based platform with a variety of exceptional imaging
modes. Grey-scale ultrasound is the most common assessment method to detect tumour size, these are typically
underestimated in biopsy-proven cancers¹, but with the addition of the SuperSonic MACH 30 and its ShearWave™ PLUS
elastography, you may reach more accurate tumour size estimation² and clear margin
definition in the preoperative setting.
Innovative imaging modes, all on one system
ShearWave PLUS elastography
A non-invasive, reliable and reproducible approach technology capable of measuring tissue stiffness in real-time. A complementary tool for the management of breast cancer patients for lesion characterisation³ and therapy monitoring.⁴
3D Breast imaging software
Acquires 3D images of the breast that offer unique visualisations of breast anatomy and detailed characterisation of lesions.
Needle PLUS imaging
Addressing the challenge of limited needle visibility and the need to predict needle trajectory. This real-time imaging mode allows you to perform biopsies with precision and confidence.
To learn more about the benefits of the
SuperSonic MACH 30
References. 1. Mullen R, Thompson JM, Moussa O, et al. (2014).
Shear-wave elastography contributes to accurate tumour size estimation when assessing small breast cancers. Clinical Radiology.
69(12):1259-63. doi: 10.1016/j.crad.2014.08.002. 2. Farrokh A, Maass N, Treu L, et al. (2018). Accuracy
of tumor size measurement: Comparison of B-mode ultrasound, strain elastography, and 2D and 3D shear wave elastography with
histopathological lesion size. Acta Radiologica. 60(4):451-458. doi: 10.1177/0284185118787354. 3. Evans A
Whelehan P, Thomson K, et al. (2012). Differentiating benign from
malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound
according to BI-RADS classification. British Journal of Cancer. 107(2):224-9. 4. Athanasiou A, Latorre-Ossa H,
Criton A, et al. (2015). Feasibility of Imaging and Treatment Monitoring of Breast Lesions with Three-Dimensional Shear Wave
Elastography. Ultraschall in der Medizin. 38(1),51-59. doi.org/10.1055/s-0034-1398980
EMB-02037-EUR-EN Rev 001 ©2022 Hologic, Inc. All rights reserved. Hologic, MACH, SuperSonic and associated logos are
trademarks or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other
trademarks, registered trademarks and product names are the property of their respective owners. This information is intended for
medical professionals and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic
materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials
appear. For information on specific products available for sale in a particular country, please contact your Hologic representative or
write to euinfo@hologic.com
|
|
|
|
AuntMinnieEurope.com, 671 N Glebe Road, Suite #1610, Arlington, VA 22203 USA
+1 520-298-1000
|
